Flow cytometric analysis of tumor infiltrating lymphocytes

MR Marie D. Ralff
AJ Aakash Jhaveri
JR Jocelyn E. Ray
LZ Lanlan Zhou
AL Avital Lev
KC Kerry S. Campbell
DD David T. Dicker
ER Eric A. Ross
WE Wafik S. El-Deiry
request Request a Protocol
ask Ask a question
Favorite

Three weeks after the initiation of treatment with a vehicle control or ONC201, the mice bearing E0771 tumors were sacrificed. Their tumors were removed and were crushed and filtered. Dissociated cells were collected and incubated with red blood cell lysis buffer. Afterwards, cells were washed with FACS buffer and incubated for 10 minutes on ice with a mouse CD16/CD32 specific antibody to block Fc receptors (eBioscience, cat # 14-0161-81). Cells were then incubated with primary antibodies from eBioscience for 30 minutes on ice in the dark (CD45: cat # 63-0451-82, CD19: cat # 48-0193-82, CD3: cat # 47-0032-82, NK1.1: cat # 17-5941-82). Cells were washed and resuspended in FACS buffer with 1 μg/mL propidium iodide added for dead cell exclusion. The cells were analyzed using an LSR II flow cytometer (BD Biosciences), and FlowJo software was used to perform data analysis.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A